1. 1

2. 1. 2553
2553
1. 754.63
2. 894.28
3. OP&IP . 72.25
4. (PP)
4.1 P&P 271.79
4.2 ( IP) 11.36
5. / / 186.00
6. ( ) 148.69
7. 8.08
8. 41 -
9. 0.78
10. 40.00
11. 2.00
12. 10.63
13. 0.84
2
( / ) 2,401.33

3. ( ) P&P 2553
P&P Capitation 271.79
. UC
(199.22 . 64.446 )
46.2397
NPP &Central P&P Expressed P&P Area based
Procurement ( PP Community)
demand
(58.41)
(15.17) (125.64)
.
Itemized Capitation
10 (93.85)
(31.79)
• Diff. by age group Area
• problem .
(18.41) (40.00)
CUP
3

4. PPA 2553
8
PPA
(58.41 . 4,797,642 )
PPA 2 : 18.41 ./ .(31.52%) PPA 1 : 40 ./ .(68.48%)
. 13.41 ./ . 4.40 / .
PPA 0.60 / .
64,336,379.22 2,878,585.20 21,109,624.80
12.41
/ .
59,538,737.22 / 0.40
/ . .PP 4.00 / . .
1,919,056.80 19,190,568.00 (40.00)
0.40 / .
1.00 / . 1,919,056.80
4,797,642
0.20 / .
959,528.40

5. P&P National Priority
and Central Procurement
1) Central Procurement
Vaccine VMI 810
PKU 3
2) National Priority Program 2552
5

6. P&P Expressed Demand
1. P&P :
2. 2
2.1 Capitation
( 25 %) ./
OP/IP
2.2 Itemization
6

7. P&P Expressed Demand
(Capitation )
P&P
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
7

8. P&P Expressed Demand
(Itemization)
1. P&P
2. P&P
3. P&P
1.
2.
( Clinical & Financial Audit )
8

9. P&P Expressed demand – Itemized(1)
Total Target pop ( )
1 ANC 329,963 ( ) •ANC <= 12 wk. 500 /
* 131,985 ( ) ( 7 •ANC 1,200 •ANC
) 400
2 PNC 516,942 ( ) . • 150 (
)
3 FP* & ( = = 40 , = 60 , =
183,661 , = 41,995 , = 1,622 , 500 , = 2,200 ( )
= 585 )
4 Vaccine ( 10,359,009 ( ) 10 / dose( )
OPV) ( .
VMI )
5 TSH* 659,927 ( ) - 140 /
( )
TSH 6,599 ( ) - 250 / (
)
6 6-12 *
- .1, .3, .6 2,400,000 ( ) 7 /
- (Sealant) .1, 1) 50 % . 1 =400,000 130 /
.6
2) 20 % .6 =160,000
9
560,000 2

10. P&P Expressed demand – Itemized(2)
Total Target pop ( )
7 4 *
4,400,000
DM HT Stroke Obesity 50 /
(confirm screening)
8 * 200,000
< 2000 /
*DM,HT,Stroke,Obesity
9 * UC & SSS
- VIA 100,000 70 /
- 3,000 160 /
- Pap Smear 1,991,600 250 /
10
1. ( 9
2 +ve)
2. 8
148,800
9 >=7) 300 /
3.
9Q,8Q +ve
10

11. Itemized
Individual data
1. OP/PP individual record ( 18 , 12+8 )
2. E-Claim
3. PPIS ( )
4. Sealant Program ( )
5. Pap-registry ( )
6. Depression ( )
7. . ( TSH )
11

12. PPA
(58.41 . 4,797,642
)
PPA 2 : 18.41 ./ .(31.52%) PPA 1 : 40 ./ .(68.48%)
. 13.41 ./ . PPA 0.60 / . 4.40 / .
64,336,379.22 2,878,585.20 21,109,624.80
.
12.41 / .
P&P .PP 4.00 / . (40.00)
59,538,737.22 0.40 / .
0.40 / . 19,190,568.00
1,919,056.80
1,919,056.80
1.00 / . 0.20 / .
4,797,642 959,528.40

13. P&P Area – based
1. .
2. .
1.
2.
3.
4.
13

14. P&P Area – based
Global ( .)
1. 40 / .
2. 18.41 / .
P&P .
1 . . 52
- UC SSS
- .
1. . . . 52 . . 52
18.41 / .
2. ( . . 52)
. . 52
14

15. P&P Area – based
1.
2. .
3. P&P
4. P&P 10%
.
5.
15

16. .
2.1
2.2 Prevention - ( .6)
2.3
2.4
2.5 . .
16

17. 2549-2552
2,281 2,904
1,961 978
375 3,030
./
1,858 310
76 450
1,167 (2009) 315 906
423 724
6,012 17,235
41,005